Eli Frydman, PdD, MBA
Managing director health care at Aurum Ventures MKI
With 17 years diverse industry experience, Eli is currently Managing Director – Healthcare for Aurum Ventures MKI. Prior to his current position, he served as the Chief Business Officer of FutuRx, the drug development incubator established by J&J, Orbimed and Takeda.
Prior to that, Eli served for 10 years as the COO of Aposense Ltd., a drug development and molecular imaging company (TASE: APOS), with responsibilities for business development, operations and finance.
Before joining Aposense, he served as a Senior Business Development manager at GE Healthcare Europe (based in France), doing healthcare M&A across Europe.
Eli holds an MBA from the Ecole des Ponts, in Paris, and a PhD in Chemistry (nanotechnology) from the Weizmann Institute of Science.
